Delain, M <br/><br/>
VAD-PECC regimen in the treatment of advanced-stage multiple myeloma.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Dec 1994 
 - 2706-13 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1994.12.12.2706  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carmustine--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Dexamethasone--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Neoplasm Staging<br/>Prednisone--administration & dosage<br/>Prognosis<br/>Prospective Studies<br/>Regression Analysis<br/>Survival Analysis<br/>Treatment Outcome<br/>Vincristine--administration & dosage<br/>Vindesine--administration & dosage